María Alejandra Rodríguez Brilla

Dr. María Alejandra Rodríguez Brilla

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2024 in HAND
Verified
Journal Article
Closed access
MSMikaela H. Sullivan
Mikaela H. Sullivan
MBMaría Alejandra Rodríguez Brilla
María Alejandra Rodríguez Brilla
CKChristopher J. Klein
Christopher J. Klein
ASAlexander Y. Shin
Alexander Y. Shin
Recent literature has emphasized the role of hand surgeons in screening patients with carpal tunnel syndrome (CTS) for amyloidosis by performing a carpal tunnel synovial biopsy during open carpal tunnel release (CTR). This has led to misconceptions about the diagnostic utility of synovial biopsy and the clinical evaluation of suspected amyloidosis. Controversy over carpal tunnel biopsy is exacerbated by minimally invasive advances in CTR procedures. This current perspective aims to determine the role of carpal tunnel synovial biopsy in amyloidosis and provide an update for hand surgeons regarding the nuances of amyloidosis. We conclude that carpal tunnel synovial biopsy should not be performed without CTS symptoms but only in patients meeting criteria for open CTR such as in those with severe symptoms which have failed nonoperative treatment and minimally invasive procedures are contraindicated. A screening approach for amyloidosis is proposed in patients presenting with CTS symptoms. Despite advances in the understanding, treatment, and diagnosis of amyloidosis, there remains a need for accurate, specific, and sensitive diagnostic tests.

17 September 2025 in Revista Colombiana de Ortopedia y Traumatología
Verified
Journal Article
Open access
PDF file
JRJheremy Sebastian Reyes-Barreto
Jheremy Sebastian Reyes-Barreto
MBMaría Alejandra Rodríguez Brilla
María Alejandra Rodríguez Brilla
Introduction: Artificial intelligence (AI) and machine learning (ML) are being increasingly implemented in the surgical treatment of scoliosis in adults in an effort to enhance precision, optimize outcomes, and support clinical decision-making. Despite significant progress, their use in the clinical setting raises ethical concerns regarding data governance, transparency, and algorithmic bias. Objective: To systematically review the current evidence on the use of AI in the context of surgical treatment of scoliosis in adults, focusing on its clinical applications, reported outcomes, and associated ethical considerations. Methodology: This systematic review was conducted in accordance with the PRISMA 2020 guidelines and registered in PROSPERO (CRD42024585554). A comprehensive search was performed in June 2024 across PubMed, ScienceDirect, Scopus, and Google Scholar. Studies addressing the use of AI or ML in the surgical treatment of scoliosis in adults (≥18 years) and reporting clinical applications, surgical outcomes, or ethical implications were included. Quality assessment was performed using the Newcastle-Ottawa Scale. Results: A total of 304 records were retrieved from the searches. After removing duplicates and screening titles, abstracts, and full-text, 16 studies were included in the review. All studies were published between 2020 and 2024; 8 were observational studies, 1 was a systematic review, and 7 were literature reviews. The combined sample size of observational studies was 43 320 patients (141-39 254). Artificial Neural Networks (ANN), Convolutional Neural Networks (CNN), and Support Vector Machines (SVM) were predominant. Clinical applications encompassed predictive modeling of surgical outcomes, assessment of complication risks, and decision support for surgical planning. AI-enhanced systems showed potential to reduce complications and improve alignment outcomes. However, external validation was limited, and no study included prospective clinical trials. Ethical concerns such as transparency and data bias were acknowledged in only a minority of studies. Conclusion: AI holds a considerable potential in scoliosis surgery for adults but it is still in early stages of clinical integration. Future research must focus on validation, explainability, and equitable implementation to fully realize its potential in spine surgery.

27 August 2025 in Revista Hematología
Verified
Journal Article
Open access
PDF file
JBJheremy Sebastian Reyes Barreto
Jheremy Sebastian Reyes Barreto
MBMaría Alejandra Rodríguez Brilla
María Alejandra Rodríguez Brilla
MEMp Montoya Estrada
Mp Montoya Estrada
JRJd Guevara Ramirez
Jd Guevara Ramirez
LFLA Gaona Fernández
LA Gaona Fernández
JCJe Reyes Castellanos
Je Reyes Castellanos
Introduction. Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with poor survival rates, especially in relapsed/refractory cases. While CAR-T cell therapy has transformed the management of other hematologic cancers, its application in AML remains limited, due to antigen heterogeneity and safety concerns. Methods. This systematic review analyzed 43 studies published between 2020 and 2024 to evaluate the efficacy and safety of CAR-T cell therapies targeting antigens such as CLL-1, CD33, CD123, and CD70 in AML. Data were extracted on survival outcomes, adverse events and antigen-specific responses. Results. CLL-1 demonstrated the most favorable outcomes, with a 60% survival response at 6.2 months in adults and 75% in pediatric patients. CD33 and CD123 showed moderate efficacy but were associated with higher hematologic toxicities. CD70 exhibited promising response rates but significant side effects (85% in preclinical studies). Emerging antigens like B7-H3 and dual-target strategies showed potential to improve outcomes by addressing antigen escape and tumor heterogeneity. Conclusions. CAR-T therapies targeting CLL-1 are highly promising for AML, offering high specificity and manageable toxicity. However, broader clinical adoption requires addressing challenges related to antigen variability and safety. In Colombia, the implementation of CAR-T therapies could revolutionize AML management but requires overcoming barriers such as cost, infrastructure, and local research capacity.

10 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
MBMaría Alejandra Rodríguez Brilla
María Alejandra Rodríguez Brilla
KKKevin Daniel Kausen
Kevin Daniel Kausen
AAAboozar Taiyeb Ali
Aboozar Taiyeb Ali
GPGovinda Paudel
Govinda Paudel
VBVictor Bautista-Hernandez
Victor Bautista-Hernandez
Vascular rings are a rare congenital anomaly of the aortic arch, in which a ring-shaped structure forms, surrounding the trachea and/or esophagus, potentially causing compression. We describe the case of a 14-month-old female patient with failure to thrive secondary to dysphagia, and a vascular ring formed by a right aortic arch, an aberrant left subclavian artery, and a left ligamentum arteriosum. Surgical repair involved ligamentum arteriosum division, Kommerell’s diverticulum obliteration, and left subclavian artery re-implantation into the left carotid artery. Endoscopy and EndoFLIPTM evaluated the intraoperative improvement in esophageal narrowing and impedance, respectively. The postoperative period was uneventful, and follow-up visits demonstrated dysphagia resolution and a patent re-implanted left subclavian artery.

24 April 2024 in Annals of Thoracic Surgery Short Reports
Verified
Journal Article
Open access
MBMaría Alejandra Rodríguez Brilla
María Alejandra Rodríguez Brilla
KKKevin Daniel Kausen
Kevin Daniel Kausen
AOAriana Ollé
Ariana Ollé
VBVictor Bautista-Hernandez
Victor Bautista-Hernandez
Aneurysms of the superior vena cava are rare vascular malformations of systemic veins. This report presents the case of a 27-year-old woman with an incidental finding of mediastinal shadow widening on the chest roentgenogram that was confirmed by computed tomographic angiography to be a superior vena cava saccular aneurysm >4 cm in diameter. Surgical resection was recommended on the basis of aneurysmal size and shape and was performed through median sternotomy by using cardiopulmonary bypass. The postoperative period was uneventful. During follow-up visits she remained asymptomatic. Saccular aneurysm surgery was recommended to prevent associated complications, including rupture, thrombosis, or venous obstruction.

9 August 2024 in Hematology & Transfusion International Journal
Verified
Journal Article
Open access
PDF file
JRJheremy S Reyes
Jheremy S Reyes
JRJheremy E Reyes
Jheremy E Reyes
LPLaura T Picón
Laura T Picón
MBMaría Alejandra Rodríguez Brilla
María Alejandra Rodríguez Brilla
Introduction: This systematic review synthesizes current evidence on the role of PIWI-interacting RNAs (piRNAs) in leukemia and lymphoma, emphasizing their potential as diagnostic markers and therapeutic targets. Leukemia and lymphoma represent significant challenges in oncology, warranting exploration of novel biomarkers beyond conventional methods. piRNAs, a class of small non-coding RNAs, exhibit dysregulated expression in tumor tissues and biological fluids, suggesting their utility in disease diagnosis and targeted therapy. Methods: A systematic search was conducted in PubMed and ScienceDirect databases following PRISMA guidelines. Eligible studies explored piRNA expression, diagnostic efficacy in leukemia and lymphoma tissues, and therapeutic implications. Included studies spanned from 2000 to 2024 and underwent rigorous quality assessment. Results: Initially identifying 26 papers, the review included 5 studies meeting inclusion criteria. These studies identified specific piRNAs, such as piR-32877 and piR-30473, with significant diagnostic potential in leukemia and lymphoma (AUC = 0.78). Insights from extracellular vesicle-derived piRNAs, like piR-36225, suggested promising applications for disease monitoring (AUC = 0.69). Conclusions: piRNAs emerge as promising biomarkers for non-invasive diagnosis and therapeutic targets in leukemia and lymphoma. Future research should validate these findings across diverse populations and elucidate underlying mechanisms to advance clinical utility.